Opportunity Information: Apply for RFA DK 18 031
This funding opportunity (RFA DK 18 031) is a National Institutes of Health cooperative agreement (U01; clinical trial required) under the Department of Health and Human Services, designed to tackle two tightly linked problems in the U.S. hemodialysis population: high levels of pain and unusually frequent, often high-dose opioid prescribing. The program is part of the NIH HEAL Initiative and is built around the idea that end-stage renal disease (ESRD) patients receiving in-center hemodialysis (HD) represent a unique, high-risk group where pain management, mental health, and opioid exposure intersect. The opportunity highlights that pain is common among Medicare ESRD HD patients, yet its reported prevalence varies markedly across regions, dialysis facilities, and potentially by ethnicity. It also notes that pain perception is associated with poorer quality of life and psychosocial factors such as limited social support, depressed mood, and other mental health disorders, making the problem broader than physical symptoms alone.
A central justification for the program is the unusually high rate of chronic opioid prescribing in this population. The announcement cites that roughly 20 percent of U.S. ESRD HD patients receive chronic opioid prescriptions, substantially higher than comparable Medicare populations. It further emphasizes that doses prescribed to HD patients can exceed CDC recommendations and that both opioid prescribing and higher dose levels are associated with worse clinical outcomes, including increased hospitalizations and mortality. In other words, the opportunity frames opioid exposure in dialysis patients not simply as a marker of severe illness, but as a potentially modifiable risk factor that may be contributing to preventable harm.
The HOPE Consortium structure is intended to support a coordinated, multi-site effort that can design, test, and monitor interventions at scale. The consortium is planned to include a single Scientific and Data Research Center (SDRC) and approximately five to six Clinical Centers (CCs). This specific opportunity is for the SDRC, which is expected to function as the organizing, analytic, and data-driven backbone of the consortium. While the full operational details are not provided in the excerpt, the SDRC role in a U01 consortium typically includes responsibilities such as harmonizing protocols across sites, developing and maintaining data systems, coordinating study operations and reporting, supporting statistical design and analysis, and enabling consistent implementation and evaluation of the intervention(s) across all participating clinical centers.
Programmatically, the consortium is expected to develop an integrated intervention that addresses pain and opioid use simultaneously in U.S. hemodialysis populations through two complementary strategies. First, it seeks to initiate multipronged, individualized, non-opioid pain treatment tailored to each patient. This reflects an emphasis on improving pain care while reducing reliance on opioids rather than focusing only on tapering or restriction. Second, for patients already affected by opioid dependence or problematic opioid use, the consortium aims to evaluate approaches that reduce dependence on full opioid agonists, including buprenorphine and other novel agents. The announcement specifically underscores that medical interventions such as naloxone and buprenorphine have not been adequately evaluated through randomized controlled trials in HD patients who use opioids, signaling a research gap the program intends to fill.
The opportunity also calls attention to underused non-pharmacologic and supportive approaches. It notes that behavioral modification strategies like cognitive behavioral therapy and group therapy, as well as social media or platform-based tools intended to share information and strengthen social support, have not been broadly employed in this population to reduce opioid prescribing and use while also addressing related comorbidities such as depression, anxiety, and pain. By naming these approaches explicitly, the announcement frames the desired intervention as potentially multidimensional, combining medical management with behavioral health and social support components, rather than treating pain and opioid exposure as isolated issues.
A key reason the ESRD hemodialysis setting is seen as ideal for this work is its built-in longitudinal structure. Patients receive ongoing, frequent, and closely monitored treatment in dialysis units, and the care environment produces rich clinical and administrative data streams. This continuous engagement and data availability can make it easier to launch interventions, track adherence and outcomes, and conduct rigorous evaluations, including randomized controlled trials. The U01 cooperative agreement mechanism further implies substantial NIH scientific and programmatic involvement, meaning the awardee is expected to collaborate closely with NIH and other consortium members to shape study design, data standards, and execution.
From an applicant and administrative perspective, the opportunity was released by NIH on December 10, 2018, with an original closing date of March 27, 2019. It anticipated a single award for the SDRC, with an award ceiling of $750,000. Eligibility was broad and included various government entities, public and private institutions of higher education, tribal governments and organizations, nonprofits (including 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), small businesses, and other applicants as allowed by the announcement. The listed CFDA numbers were 93.847 and 93.866, and the activity area was categorized under health (with additional categorization fields referencing food and nutrition/health).
Overall, this grant opportunity is aimed at building the centralized scientific, operational, and analytic hub for a national consortium that will develop and rigorously test integrated strategies to improve pain management and reduce harmful opioid exposure among hemodialysis patients. The emphasis is on interventions that are patient-tailored and non-opioid for pain whenever possible, coupled with evidence-based medication approaches like buprenorphine for individuals with opioid dependence, all evaluated in a structured, multi-site clinical trial environment supported by robust longitudinal dialysis data.Apply for RFA DK 18 031
- The Department of Health and Human Services, National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Scientific and Data Research Center (U01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847, 93.866.
- This funding opportunity was created on Dec 10, 2018.
- Applicants must submit their applications by Mar 27, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $750,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Food and Nutrition, Health
Next opportunity: Disability and Rehabilitation Research Projects (DRRP) Program: Community Living and Participation (Development)
Previous opportunity: U.S. Embassy Moscow Public Affairs Section FY 2019 Annual Program Statement (APS) Small Grants
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 18 031
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 18 031) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition for the Continuation of the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) Apply for RFA DK 18 509 Funding Number: RFA DK 18 509 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $15,000,000 |
| Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed) Apply for RFA DK 18 008 Funding Number: RFA DK 18 008 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $650,000 |
| Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed) Apply for RFA DK 19 006 Funding Number: RFA DK 19 006 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $130,000 |
| Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) Apply for RFA DK 19 002 Funding Number: RFA DK 19 002 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $750,000 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) Apply for RFA DK 19 004 Funding Number: RFA DK 19 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $750,000 |
| Limited Competition: Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY) (U01 Clinical Trial Not Allowed) Apply for RFA DK 18 512 Funding Number: RFA DK 18 512 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $9,000,000 |
| (Re)Building a Kidney (UC2 Clinical Trial Not Allowed) Apply for RFA DK 19 007 Funding Number: RFA DK 19 007 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
| Catalyst Award In Diabetes, Endocrinology and Metabolic Diseases (DP1 Clinical Trial Not Allowed) Apply for RFA DK 19 014 Funding Number: RFA DK 19 014 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
| Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) Apply for RFA HL 20 030 Funding Number: RFA HL 20 030 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Exploratory Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Optional) Apply for RFA DK 19 033 Funding Number: RFA DK 19 033 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $200,000 |
| Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers (T1DAPC-CCs) (U01 Clinical Trial Optional) Apply for RFA DK 19 022 Funding Number: RFA DK 19 022 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $175,000 |
| Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional) Apply for RFA DK 19 023 Funding Number: RFA DK 19 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) Apply for RFA DK 20 006 Funding Number: RFA DK 20 006 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $130,000 |
| Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) Apply for PAR 20 140 Funding Number: PAR 20 140 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $200,000 |
| George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional) Apply for RFA DK 20 008 Funding Number: RFA DK 20 008 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $1,000,000 |
| NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) Apply for RFA DK 20 024 Funding Number: RFA DK 20 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
| NIDDK Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) - Generated Resources (R25 Clinical Trial Not Allowed) Apply for RFA DK 20 020 Funding Number: RFA DK 20 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $120,000 |
| Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed) Apply for RFA DK 20 014 Funding Number: RFA DK 20 014 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $750,000 |
| Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required) Apply for RFA DK 20 032 Funding Number: RFA DK 20 032 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $225,000 |
| Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional) Apply for RFA HL 21 014 Funding Number: RFA HL 21 014 Agency: Department of Health and Human Services, National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 18 031", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.